Recent advancement in drug development of nitro(NO<sub>2</sub> )-heterocyclic compounds as lead scaffolds for the treatment of Mycobacterium tuberculosis.
第一作者:
Cauê Benito,Scarim
第一单位:
Department of Cell and Molecular Biology, University of Mississippi Medical Center (UMMC), Jackson, Mississippi, USA.
作者:
医学主题词
抗结核药(Antitubercular Agents);杂环化合物(Heterocyclic Compounds);人类(Humans);微生物敏感性试验(Microbial Sensitivity Tests);结核分枝杆菌(Mycobacterium tuberculosis);二氧化氮(Nitrogen Dioxide);结核(Tuberculosis)
DOI
10.1002/ddr.21921
PMID
35106801
发布时间
2022-08-18
- 浏览10
Drug development research
842-858页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



